However, Konig et al. (177) argue, that the central role of ACPA is to break tolerance during RA development and they propose, that loss of tolerance is a consequence of the presence of antibodies against native proteins, which precede generation of ACPA. The gene discussed is PRTN3; the disease is rheumatoid arthritis.